Exports in Indian Pharma likely to Surge 15% in FY24

Exports in the India's pharmaceutical sector to the US have surged 15% in the first 11 months of the financial year 2024 despite being faced with many regulatory challenges and rise in product pricing pressures.

SaniSure Advances Drug Speed To Market with Fill4Sure Launch

SaniSure, a worldwide player in single-use bioprocessing items, has declared the launch of Fill4Sure, a custom single-use filling gathering intended to facilitate drugs to market and construct security, effectiveness and repeatability into your...

Bank of Maharashtra's MAHADOC Loan Scheme for Doctors: Empowering Medical Professionals, Building a Healthier Nation

A nation's healthcare system is only as strong as its infrastructure. From well-equipped hospitals to specialized clinics, a robust network of facilities is essential for delivering quality healthcare to every citizen.

India's Pharmaceutical Exports To USA Increase 15% in 11 months of FY24

India's pharmaceutical exports to the USA increased by 15% in the first 11 months of the last monetary year despite administrative difficulties and rising estimating pressures. The speed of exports has dramatically increased from the 6.18%...

Harmony Biosciences Sign Pact with Bioprojet To Develop TPM 1116

Harmony Biosciences, a dedicated firm in creating and conveying medicines for uncommon neurological sicknesses, has declared a licensing contract with Bioprojet to create, make and popularize TPM-1116, an exceptionally strong and specific oral...

US FDA Grants Nod For Clinical Trials of Lamassu Biotech's Cancer Treatment

Lamassu Bio Inc., a cutting-edge biotech organization, is pleased to report that its spearheading work to battle privately progressed metastatic p53 wild-type cancers has secured investigational new drug application (IND) endorsement from the US...

Novartis Forays into a Pact with Arvinas For USD 1.01 Billion

Swiss drugmaker Novartis AG has signed a licensing agreement with Arvinas worth up to $1.01 billion to acquire access to the U.S. biotech firm's experimental prostate cancer medication, Arvinas added. The agreement strengthens Novartis' pursuit...

Macomics Launches Monoclonal Antibody For Cancer Treatment

Macomics Ltd, a biotechnology firm, has revealed information about its lead program, a first-in-class ligand independent-pan-LILRB monoclonal antibody for the treatment of cancer, having introduced key information on MACO-355 at the American...

Vertex Pharma To Buy Alpine Immune Sciences For USD 4.9 Billion

The biotechnology companies Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences centered on finding and creating imaginative, protein-based immunotherapies, declared that the organizations have gone into a definitive contract under...

Digostics and AgaMatrix Partner to Improve Gestational Diabetes Screening

Digostics Limited, a leading diabetes home testing provider, has declared a business alliance with AgaMatrix Europe Limited, a driving diabetes innovation organization. The alliance Is intended to speed up the presentation of Digostics' home oral...

© 2024 India Pharma Outlook. All Rights Reserved.